Comparative Glycemic Effectiveness of Four Second-Line Glucose-Lowering Medications in Type 2 Diabetes Mellitus

Related

• SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes

  Clinical Journal of the American Society of Nephrology · 4 Oct 2026

• GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk

  Diabetes, Obesity & Metabolism · 4 Oct 2026

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• Drug class linked to fewer deaths or complications in kidney disease

  The American Journal of Cardiology · 8 Oct 2026